Subscribe biotechnology, chronic disease, CMS, Donald Trump, Drug prices, Medicaid, Medicare, Medicare negotiation, Obesity, Pharmaceuticals, Policy, STAT+ Daniel covers the intersection of the health industry and the federal government
Metoclopramide: Prescription option that both reduces nausea and promotes gastric emptying, addressing the underlying slow motility causing symptoms
In animal experiments on such drugs, studies on rodents have found that the GLP-1RAs may promote the development of medullary thyroid carcinoma, but this effect has not been observed in non-human primates [23]
Can a psychiatrist legally prescribe GLP-1 weight-loss medications
Schulthei C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes SS, et al